Press "Enter" to skip to content

Allergan signs $750 million settlement with purchasers of Alzheimer’s drug Namenda

Purchasers of Allergan Plc’s Namenda asked a federal judge on Tuesday to approve a $750 million settlement of claims that the drugmaker conspired to keep generic versions of the Alzheimer’s medication off the market.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/6ty-aeHoeNE/allergan-signs-750-million-settlement-with-purchasers-of-alzheimers-drug-namenda-idINKBN1YS1C4